Current Report Filing (8-k)
04 10월 2022 - 5:38AM
Edgar (US Regulatory)
0001626644
false
0001626644
2022-09-29
2022-09-29
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
U.S. SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
Current Report Pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of
earliest event reported): September
29, 2022
ODYSSEY
HEALTH, INC.
(Exact name of small business
issuer as specified in its charter)
| Nevada |
000-56196 |
47-1022125 |
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer ID No.) |
2300
West Sahara Avenue, Suite 800 - #4012,
Las
Vegas, NV |
89102 |
| (Address of principal executive offices) |
(Zip Code) |
(702) 780-6559
(Issuer’s
Telephone Number)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant
to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
| N/A |
N/A |
N/A |
Securities registered pursuant
to Section 12(g) of the Act:
| Title of each Class |
Trading Symbol |
Name of Each Exchange on Which Registered |
| Common Stock ($0.001 par value) |
ODYY |
OTC |
Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or
Rule 12b2 of the Securities Exchange Act of 1934 (§240.12b2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 1.01 |
Entry into a Material Definitive Agreement. |
On September 29, 2022, Odyssey Health, Inc., f/k/a
Odyssey Group International, Inc. (the “Company”), entered into Amendment No. 3 to the Convertible Promissory Note (the “Amendment”)
to the Securities Purchase Agreement dated April 5, 2021, with LGH Investments, LLC (“LGH”). Pursuant to the Amendment, the
parties have agreed to extend the maturity date of the note to December 31, 2022. As consideration, one-hundred fifteen thousand ($115,000)
shall be added to the principal amount outstanding. All other terms and conditions remain the same.
On September 30, 2022, the Company entered into
five Promissory Note Amendments (the “Amendments”), to the Promissory Notes entered into December 21, 2021 and December 22,
2021 and as amended April 20, 2022, and June 3, 2022, with three directors and two officers of the Company. Pursuant to the Amendments,
the parties have agreed to extend the maturity date of the note to December 31, 2022. All other terms and conditions remain the same
The Amendment No. 3 and Promissory Notes Amendments
are attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
| Item 2.03. |
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. |
The information set forth above under Item 1.01 is hereby incorporated
by reference into this Item 2.03.
| Item 9.01 |
Financial Statements and Exhibits |
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
Odyssey Health,
Inc. |
| |
|
| |
By: |
/s/ Joseph Michael Redmond |
| |
|
Joseph Michael Redmond
Chief Executive Officer |
Date: October
3, 2022
Odyssey (QB) (USOTC:ODYY)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Odyssey (QB) (USOTC:ODYY)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
